Macrocyclic hepatitis C serine protease inhibitors

The present invention relates to compounds of Formula I, II or III, or a pharmaceutically acceptable salt, ester, or prodrug, thereof:

Saved in:
Bibliographic Details
Main Authors Miao, Zhenwei, Sun, Ying, Nakajima, Suanne, Tang, Datong, Wu, Frank, Xu, Guoyou, Or, Yat Sun, Wang, Zhe
Format Patent
LanguageEnglish
Published 28.02.2012
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to compounds of Formula I, II or III, or a pharmaceutically acceptable salt, ester, or prodrug, thereof: